Cambridge Investment Research Advisors’s Silence Therapeutics SLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$59K Buy
+10,194
New +$59K ﹤0.01% 3525